Loss of function variant in SMIM1 is associated with reduced energy expenditure and weight gain

Mattia Frontini(National Health Service), Dragana Vuckovic(Imperial College London), Nadia Schoenmakers(Addenbrooke's Hospital), Omer Ali Bayraktar(Wellcome Sanger Institute), Ana R. Tomé(Universidade Nova de Lisboa), Willem H. Ouwehand(NHS Blood and Transplant), Antonio Vidal‐Puig(University of Cambridge), Jo Piper(Cambridge University Hospitals NHS Foundation Trust), Henrik Ullum(Statens Serum Institut), Wendy N. Erber(The University of Western Australia), Nicholas Gleadall(University of Cambridge), Jamie H. Warner(The University of Texas at Austin), Michèle Vacca(University of Cambridge), Luca Stefanucci(Wellcome Sanger Institute), Karola Rehnström(National Health Service), Gail Biggs(Cambridge University Hospitals NHS Foundation Trust), P H Baker(Cambridge University Hospitals NHS Foundation Trust), Krishna Chatterjee(University of Cambridge), Jing E. Kwa(Wellcome Sanger Institute), Martin L. Olsson(Lund University), Keith Burling(Cambridge University Hospitals NHS Foundation Trust), Klaus Rieneck(Rigshospitalet), Jill R. Storry(Lund University), Morten Hanefeld Dziegiel(University of Copenhagen), Sisse Rye Ostrowski(University of Copenhagen), Sam Virtue(University of Cambridge), Urmo Võsa(University Medical Center Groningen), Sofie Ashford(University of Cambridge), Christian Erikstrup(Aarhus University Hospital), Laura Watson, Amy Frary(University of Cambridge), Samantha Farrow(National Health Service), Vian Azzu(AstraZeneca (United Kingdom)), Ji Chen(Emory University), Frances Burden(National Health Service), Gary J. Hoffman(The University of Western Australia), William J. Astle(National Health Service), Ole Lederballe Pedersen(Aarhus University Hospital), Camous Moslemi(Aarhus University Hospital)
Research Square
January 24, 2022
Cited by 0


Related Papers